The FDA has authorized 20 ZYN nicotine pouch products from Philip Morris International (NYSE: PM), marking the first approval of its kind. After a thorough review, the FDA confirmed these products ...
We came across a bullish thesis on Philip Morris International Inc. (PM) on Substack by Chit Chat Stocks. In this article, we ...
Analysts have been eager to weigh in on the Consumer Goods sector with new ratings on Philip Morris (PM – Research Report) and Church & ...
Shares of Philip Morris International Inc. ($PM) rose more than 1% on Thursday after the US Food and Drug Administration (FDA ...
Fintel reports that on January 16, 2025, Morgan Stanley initiated coverage of Philip Morris International (NYSE:PM) with a ...
In a groundbreaking move for the industry, the FDA has authorized the marketing of ZYN nicotine pouches — the first product ...
Federal health officials on Thursday backed the public health benefits of nicotine pouches, authorizing Philip Morris ...
The FDA today has set a dangerous precedent that puts the nation's kids at risk by authorizing the sale of 20 Zyn nicotine ...
Shares of Philip Morris extended their recent bounce Thursday after the U.S. Food and Drug Administration authorized the ...
U.S. health officials have cleared America's most popular nicotine pouch to stay on the market, saying Zyn's benefit as a safer alternative for adult cigarette smokers outweighed its potential risk to ...
Zyn and the retailers who sell the product have run afoul of regulators in recent years. The FDA in April of last year warned ...